文献速递妇科产科

磁共振成像预测接受根治性放化疗的膀胱侵犯宫颈癌患者膀胱阴道瘘的价值

The value of magnetic resonance imaging in predicting vesicovaginal fistula in cervical cancer with bladder invasion treated with definitive chemoradiotherapy.
PubMed 文献 · Gynecol Oncol · 2025-01-25

该回顾性研究纳入1999至2015年间43例膀胱侵犯宫颈癌患者,评估磁共振成像预测根治性放化疗后膀胱阴道瘘发生的价值。中位随访67.4个月,5例(12.8%)发生膀胱阴道瘘。多因素分析显示磁共振成像上膀胱壁侵犯高度是膀胱阴道瘘的唯一显著预测因子(p=0.041)。

要点

  • 磁共振成像膀胱壁侵犯高度是膀胱阴道瘘的独立预测因子(p=0.041)。
  • 膀胱壁侵犯≥20.3 mm、≥31.1 mm、≥41 mm时膀胱阴道瘘发生率分别为25%、50%、75%。
  • 5年无病生存率和总生存率分别为66.4%和71.8%。

核心结论

  • 磁共振成像上膀胱壁侵犯高度是膀胱侵犯宫颈癌患者发生膀胱阴道瘘的显著预测因子,可帮助临床医生更好地预测该并发症并改善患者咨询和管理策略。

研究设计与样本

  • 回顾性研究,纳入1999至2015年间43例膀胱侵犯宫颈癌患者,膀胱侵犯经磁共振成像(评分≥3)或膀胱镜检查(伴或不伴活检)确认。
  • 治疗包括每周顺铂加盆腔外照射放疗(含延伸野放疗),外照射后接受腔内近距离放疗或外照射推量。

主要发现

  • 中位随访67.4个月,5例(12.8%)发生膀胱阴道瘘,其中3例在治疗后1年内发生,另2例分别在16.7个月和64.5个月发生。
  • 5年无病生存率和总生存率分别为66.4%和71.8%。
  • 多因素分析中,磁共振成像上膀胱壁侵犯高度是膀胱阴道瘘的唯一显著预测因子(p=0.041)。
  • 膀胱壁侵犯≥20.3 mm时膀胱阴道瘘发生率为25%,≥31.1 mm时为50%,≥41 mm时为75%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the predictive value of magnetic resonance imaging for vesicovaginal fistula development in cervical cancer patients with bladder invasion treated with definitive chemoradiotherapy. METHODS: A retrospective review was conducted of the medical records of 43 cervical cancer patients with bladder invasion between 1999 and 2015. Bladder invasion was confirmed through magnetic resonance imaging (scores ≥3) or cystoscopic findings, with or without biopsy. Treatment included weekly cisplatin plus pelvic external beam radiotherapy, with extended-field radiotherapy. After external beam radiotherapy, patients received intracavitary brachytherapy or an external beam boost. Vesicovaginal fistula was diagnosed based on reported symptoms and relevant imaging tests during follow-up. RESULTS: The median follow-up period was 67.4 months. The 5-year disease-free and overall survival rates were 66.4 %, and 71.8 %, respectively. Vesicovaginal fistula developed in five patients (12.8 %), with three cases occurring within 1 year post-treatment and two others at 16.7 and 64.5 months, respectively. In multivariate analysis, the height of bladder wall involvement on magnetic resonance imaging was the only significant predictor of vesicovaginal fistula (p = 0.041). Specifically, Vesicovaginal fistula occurred in 25 % of cases when bladder wall involvement was ≥20.3 mm, in 50 % of cases at ≥31.1 mm, and in 75 % of cases at ≥41 mm. CONCLUSIONS: The height of bladder wall involvement on magnetic resonance imaging is a significant predictor of vesicovaginal fistula formation in cervical cancer patients with bladder invasion. This finding can aid clinicians in better predicting this complication, improving patient counseling and management strategies.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kim YJ, Lee J, Park S, et al. The value of magnetic resonance imaging in predicting vesicovaginal fistula in cervical cancer with bladder invasion treated with definitive chemoradiotherapy. Gynecol Oncol. 2025. PMID: 39864258. doi:10.1016/j.ygyno.2025.01.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。